Keywords: diosynth, reports, global, restructuring, ops, akzo, nobel

Diosynth reports global restructuring of ops

Article | 29 March 2004

Diosynth, Akzo Nobel's pharmaceutical ingredients manufacturing segment, has unveiled plans to restructure its chemical synthesis operations worldwide. The company is ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in

Related Companies

Akzo Nobel

Organon

Go to company listing